Prevalence of severe adverse events among health professionals after receiving the first dose of the ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021

BACKGROUND: The coronavirus disease 2019 (COVID-19) vaccines can cause adverse events that can lead to vaccine hesitancy. This study aims at estimating the prevalence of severe adverse events (SAEs) and their associated factors among health professionals vaccinated with ChAdOx1 nCoV-19 vaccine in To...

Descripción completa

Detalles Bibliográficos
Autores principales: Konu, Yao Rodion, Gbeasor-Komlanvi, Fifonsi Adjidossi, Yerima, Mouhoudine, Sadio, Arnold Junior, Tchankoni, Martin Kouame, Zida-Compaore, Wendpouire Ida Carine, Nayo-Apetsianyi, Josée, Afanvi, Kossivi Agbélénko, Agoro, Sibabe, Salou, Mounerou, Landoh, Dadja Essoya, Nyansa, Atany B., Boko, Essohanam, Mijiyawa, Moustafa, Ekouevi, Didier Koumavi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611394/
https://www.ncbi.nlm.nih.gov/pubmed/34819146
http://dx.doi.org/10.1186/s13690-021-00741-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611394/
https://www.ncbi.nlm.nih.gov/pubmed/34819146
http://dx.doi.org/10.1186/s13690-021-00741-x

Ejemplares similares